Telemark Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.6M Buy
+50,000
New +$14.8M 1.12% 32
2019
Q3
– Sell
-240,450
Closed -$17.1M – 41
2019
Q2
$17.1M Buy
+240,450
New +$17.7M 1.96% 21

Other funds holding LGND

Telemark Asset Management's LGND Position: Q3 2026 in Review

Telemark Asset Management opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 50,000 shares worth $15.6M. The stake represents 1.12% of the portfolio and ranks #32 among its holdings. This is a return to the name: Telemark Asset Management previously reported a position in LGND as recently as Q2 2019.

Telemark Asset Management first reported a position in LGND in Q2 2019 and has held it in 2 quarters since. The position peaked at $17.1M in Q2 2019. 424 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Telemark Asset Management held 50,000 shares of Ligand Pharmaceuticals worth $15.6M as of Q3 2026.
  • Ligand Pharmaceuticals was a new Telemark Asset Management position in Q3 2026.
  • Ligand Pharmaceuticals made up 1.12% of Telemark Asset Management's portfolio in Q3 2026, its #32 holding.
  • Telemark Asset Management first reported a position in Ligand Pharmaceuticals in Q2 2019 and has held it in 2 quarters since.
  • Telemark Asset Management's Ligand Pharmaceuticals position peaked at $17.1M in Q2 2019.
  • 424 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Telemark Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.